Tofogliflozin: a highly selective SGLT2 inhibitor for the treatment of type 2 diabetes. (Q53094851)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Tofogliflozin: a highly selective SGLT2 inhibitor for the treatment of type 2 diabetes. |
scientific article |
Statements
1 reference
Tofogliflozin: a highly selective SGLT2 inhibitor for the treatment of type 2 diabetes. (English)
1 reference
R F Rosenwasser
1 reference
J N Rosenwasser
1 reference
D Sutton
1 reference
R Choksi
1 reference
B Epstein
1 reference
1 November 2014
1 reference
50
1 reference
739-745
1 reference
11
1 reference
Identifiers
1 reference